According to U.S. officials, eyedrops contaminated with drug-resistant bacteria have been connected to two more fatalities and new cases of eyesight loss.
In February, the eyedrops from EzriCare and Delsam Phama were recalled, and health officials are still keeping track of infections as they look into the outbreak.
On Tuesday, the Centers for Disease Control and Prevention stated that 68 people had been diagnosed with illnesses from the bacteria, which has already resulted in three fatalities and eight cases of people losing their vision.
This is more than the one fatality and five irreversible visual loss cases recorded last month.
According to the CDC, four people had surgery to remove an eyeball due to the disease.
The attack is highly concerning because the bacteria causing the outbreak are resistant to common antibiotics.
Sixteen states, including California, New York, Illinois, Texas, and Pennsylvania, have now been identified by the CDC as having cases.
Ezricare’s drops are the sole product patients in the four regional clusters, with most cases linked to use.
The Pseudomonas aeruginosa bacteria, frequently connected to hospital outbreaks, was produced by Global Pharma Healthcare in India, where the recalled drops were made.
It may be transmitted through contaminated hands or medical supplies.